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Abstract
Microarray technology can facilitate simultaneous expression analysis of thousands of genes and assist in delineating cellular
pathways involved in development or disease pathogenesis. Since public databases and commercial cDNA microarrays have an
under-representation of eye-expressed genes, we generated over 3000 expressed sequence tags from three unampliﬁed mouse eye/
retina cDNA libraries. These eye-expressed genes were used to produce cDNA microarrays. Methodology for printing of slides,
hybridization, scanning and data analysis has been optimized. The I-gene microarrays will be useful for establishing expression
proﬁles of the mouse eye/retina and provide a resource for deﬁning molecular pathways involved in development, aging and dis-
ease.  2002 Elsevier Science Ltd. All rights reserved.
Keywords: Expression analysis; Gene proﬁle; Functional genomics; Cellular pathways; Retinal degeneration; Mouse eye mutants
1. Introduction
Molecular insights into pathogenesis of retinal dis-
eases and systematic design of therapeutic strategies
are dependent, to a large extent, on animal models
(mostly mouse) and our understanding of the basic
biological processes underlying development and main-
tenance of specialized visual functions (e.g., photo-
transduction). Pioneering studies in vertebrate systems
have demonstrated that cell fate determination and
neuronal diﬀerentiation of retinal progenitor cells is
guided by intrinsic genetic programs, inductive cell–
cell interactions and extrinsic factors (Cepko, Austin,
Yang, Alexiades, & Ezzeddine, 1996; Levine, Fuhr-
mann, & Reh, 2000), which lead to diﬀerential ex-
pression of genes at speciﬁc stages of development. A
signiﬁcant number of transcription factors and signal-
ing molecules that are expressed in developing retina
have been identiﬁed (Freund, Horsford, & McInnes,
1996; Jean, Ewan, & Gruss, 1998) and the role for at
least two such proteins in causing human eye disease
delineated (Bessant et al., 1999; Freund et al., 1997;
Swain et al., 1997; Swaroop et al., 1999). Nevertheless,
cellular targets for the molecular regulators and sig-
naling pathways leading to the speciﬁcation of retinal
neurons are poorly understood. Similarly, although a
number of retinal macular disease genes have been
identiﬁed (RetNet, http://www.sph.uth.tmc.edu/Ret-
Net/) and animal models of human retinal disease
(generally in mouse) generated, the pathways by which
mutations in a particular gene (retina-speciﬁc or widely
expressed) speciﬁcally lead to photoreceptor degenera-
tion are poorly understood.
Recent advances in genomics and microarray tech-
nology provide an excellent opportunity to examine
changes in retinal gene expression proﬁles during de-
velopment and disease. Until recently, most studies have
focused on the characterization of a limited number
of genes or proteins. The advent of microarrays has
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revolutionized the pace of investigations in functional
genomics (Hughes et al., 2000; Schena, Shalon, Davis, &
Brown, 1995; Shalon, Smith, & Brown, 1996; Yong,
2000). It is now possible to simultaneously study thou-
sands of genes that are altered at a particular stage of
development or during disease pathogenesis. Among
others, the microarrays have been successfully applied to
the generation of expression proﬁles of cell cycle (Cho
et al., 2001), hematopoietic stem cells (Phillips et al.,
2000), various cancers (Alizadeh et al., 2000; Bittner
et al., 2000; DeRisi et al., 1996; Golub et al., 1999), and
normal/diseased brain (Lee, Weindruch, & Prolla, 2000;
Mirnics, Middleton, Marquez, Lewis, & Levitt, 2000;
Sandberg et al., 2000). Generation of such gene proﬁles
is expected to lead to better insights of cellular pathways
and should have signiﬁcant impact on rational drug
design. During the last few years, several laboratories
have generated expressed sequence tags (ESTs) from
retina (Bernstein, Borst, Neuder, & Wong, 1996; Ma-
lone, Sohocki, Sullivan, & Daiger, 1999; Sinha, Sharma,
Agarwal, Swaroop, & Yang-Feng, 2000; Swanson et al.,
1997) and used small-scale microarrays for comparative
studies (Livesey, Furukawa, Steﬀen, Church, & Cepko,
2000). However, systematic investigations for generating
expression proﬁles of eye tissues, particularly retina,
have not been attempted.
Although public gene databases provide a wealth of
information, the genes expressed in the mouse (and
human) eye/retina are under-represented. Furthermore,
as much as 30% of the cDNA clones procured from
vendors may contain multiple inserts or are mislabeled
and must be re-sequenced (Halgren, Fielden, Fong, &
Zacharewski, 2001). Therefore, the goals of our studies
are to construct cDNA libraries from mouse eye/retina,
isolate sequence-tagged cDNAs, and produce custom
eye gene microarrays for developing gene expression
proﬁles. At this stage, we have analyzed over 3000
cDNA sequences and are printing slides with almost
2000 eye-expressed genes. Experiments have also been
initiated for optimization of conditions and studies on
mutant mice retina.
2. Methods
2.1. RNA isolation
Mouse embryonic day (E) 15.5 and postnatal day
(PN) two eye tissues were dissected from CD-1 mice
(Charles River Laboratory). Adult mouse retina was
dissected from C57BL/6 mice. Total RNA was isolated
using TRIzol reagent (Life Technologies) and puriﬁed
by RNeasy kit (Qiagen). Purity and integrity of RNA
was evaluated by absorbance at 260 and 280 nm and by
agarose gel electrophoresis.
2.2. cDNA library construction
Total RNA (40 lg) was used for generating direc-
tional cDNA libraries with SuperScriptTM Plasmid
System (Life Technologies). Three libraries were con-
structed in the pSPORT1 vector according to the
manufacturer’s protocol. Brieﬂy, ﬁrst-strand cDNA
was synthesized with a Not I-oligo(dT) primer-adapter.
After second-strand synthesis and ligation of Sal I
adapters, the cDNAs were digested with Not I, which
generated cDNAs with Sal I sites at the 50 end and Not I
sites at the 30 end. cDNAs were size-fractionated and
those of 0.5 to 2 kb were digested with Sal I and Not
I and ligated to pSPORT1 vector. The ligated sample
was used to transform E. coli (ElectroMax DH-5a) by
electroporation.
2.3. DNA sequencing
DNA sequencing was performed with a high
throughput automatic Sequencer (Applied Biosystems,
Inc). An average of 600 bp nucleotide sequence was
obtained from the 50 end of 3188 clones. BLAST search
(http:www.ncbi.nlm.nih.gov/BLAST) was performed
against GenBank and dbEST for each clone and a col-
lection of ESTs was assembled. Information regarding
these clones is stored in a Microsoft Excel database.
2.4. Printing of microarray slides
Individual clones were cultured in 96-well plates
containing ampicillin. After overnight incubation, these
cultures were converted into glycerol stocks that were
also used for direct ampliﬁcation of cDNA inserts. PCR
reactions in a total volume of 100 ll (2.5 mMMgCl2 and
2.5 units of Amplitaq Gold (AP Biosystems)) were
performed as follows: 95 12 min, (35 cycles: 94 30 s,
63 30 s, 72 45 s), 72 15 min. A 96-well plastic repli-
cator (Incyte Genomics) was used to seed PCR reactions
with bacteria from the glycerol stocks. PCR products
were puriﬁed using the multiscreen PCR system (Milli-
pore). Samples were then electrophoresed on agarose
gels to determine relative DNA concentrations as well
as the success rate for PCR ampliﬁcation. Four 96-well
plates of cDNA inserts were then converted to a single
384-well plate. These samples were evaporated under
vacuum and resuspended in either 4 ll of 3X sodium
chloride/sodium citrate (SSC) or 50% dimethylsulfoxide.
The samples were arrayed onto CMT-GAPS slides
(Corning) with a SDDC-2 arrayer (Virtek ESI). Printed
slides are then stratalinked and stored in a dust-free and
lightproof container until use.
2.4.1. Direct labeling of the target RNA
A mixture of total RNA (10 lg) and oligo-dT (2
lg) (in a total volume of 22 ll) was heated to 70 C
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for 10 min and quickly chilled on ice. The following
were then added sequentially: Cy3TM-dCTP (12.5 lM)
or Cy5TM-dCTP (25 lM) (Amersham), 1X ﬁrst-strand
buﬀer, DTT (10 mM) (Life Technology), dNTP mix
(0.5 mM each dATP, dGTP, dTTP, and 0.25 mM
dCTP), 40 units RNase inhibitor and 400 units Su-
perScriptTM II reverse transcriptase (Life Technology)
in a total volume of 40 ll. The reaction was incubated
at 42 C for 2 h to generate Cy3- or Cy5-labeled target
cDNA. Starting RNA was eliminated by adding 2
units of RNase H and 10 lg of RNase A for 15 min
at 37 C. Target cDNAs were puriﬁed using QIA-
quickTM PCR puriﬁcation kit (Qiagen) and concen-
trated to 10 ll.
2.4.2. Indirect labeling of the target RNA
Total RNA (16 lg) and oligo-dT (5 lg) were com-
bined in a total volume of 15.5 ll, incubated at 70 C for
10 min and quickly chilled on ice. The following were
added to a total volume of 30 ll: 1X ﬁrst-strand buﬀer,
10 mM DTT (Life Technology), aminoallyl-dUTP/
dNTP mix (500 lM dATP, 500 lM dCTP, 500 lM
dGTP, 300 lM dTTP, 200 lM aa-dUTP), and 380 units
SuperScriptTM II reverse transcriptase (Life Techno-
logy). Each sample was incubated at 42 C for 2 h. 10 ll
of 1N NaOH and 10 ll of 0.5 M EDTA were added and
the reaction was incubated at 65 C for 15 min to hy-
drolyze starting RNA. The reaction was neutralized by
adding 25 ll of 1 M Tris-HCl, pH 7.5, and cDNAs were
puriﬁed using GFXTM columns (Amersham) and vac-
uum dried. Each cDNA pellet was resuspended in 4.5 ll
of H2O. Cy3 or Cy5 monoreactive dye (Amersham) was
each resuspended in 4.5 ll of 0.1 M sodium bicarbonate
buﬀer (pH 9.0). cDNAs and Cy3 or Cy5 were mixed and
incubated at room temperature in the dark for 1 h to
allow coupling of the dyes. To stop the reaction and
prevent cross-coupling, 4.5 ll of 4 M hydroxylamine
was added to each reaction, followed by 15 min incu-
bation in the dark. Samples were then puriﬁed using
QIAquickTM PCR puriﬁcation kit (Qiagen) and vacuum
dried.
2.5. Reference RNA
Reference RNA for microarray experiments was
generated by combining total RNAs from several
mouse tissues and cell lines. A mixture of 17 mg of total
RNA was obtained, with 7 mg from mouse retina at
diﬀerent stages of development (E14-16, PN2-3, PN10-
12 and adult), 3 mg from P19 embryonic carcinoma
cells, another 3 mg from P19 cells induced to diﬀeren-
tiate into neuronal and glial cells in the presence of
retinoic acid, and 4 mg from neuroblastoma stem cells
N1E-115.
2.6. Microarray hybridization with labeled targets
Microarray slides were prehybridized in prehybrid-
ization buﬀer (5X SSC, 1% Bovine serum albumin) and
0.1% Sodium dodecyl sulfate (SDS) at 42 C for 1 h and
washed ﬁve times in H2O for 2 s each. The slides were
then rinsed with isopropanol and centrifuged at 1900
rpm for 2 min.
An equal volume of 2X hybridization buﬀer (50%
formamide, 10X SSC, 0.2% SDS) was added to the
target mixture, consisting of Cy3 and Cy5 labeled target
cDNAs, 1 lg poly(A) RNA (Sigma), 2 lg mouse Cot-1
DNA (Life Technology), 1 lg yeast tRNA (Life Tech-
nology), and 10 lg salmon sperm DNA (Life Tech-
nology). The hybridization mixture was applied to
microarray slides. For indirect labeling, dye-labeled
cDNAs were resuspended in 45 ll of GlassHyb (Clon-
tech), heated to 95 C for 5 min and centrifuged brieﬂy
before applying to the slides. After putting a 22 40
mm coverslip (Grace Bio-Lab), each slide was placed in
a hybridization chamber (Corning Microarray Tech-
nology). Droplets of DEPC water were placed in the two
reservoirs at either end of the chamber, which was then
sealed and placed in a 42 C water bath overnight for
16–20 h. Slide microarrays were removed from the
chamber and immersed into 2X SSC until the coverslip
moved away freely. Slides were then sequentially washed
twice in 0.1X SSC, 0.1% SDS and 0.1X SSC. After
rinsing in DEPC water for 5 s, the microarrays were
centrifuged at 1900 rpm for 2 min to dry.
2.7. Slide scanning and data analysis
After hybridization and washing, slides were scanned
using an Aﬀymetrix 428 scanner. Images were acquired
for Cy3 and Cy5 channels in a 16-bit TIFF format and
then analyzed using Jaguar 2.0 (Aﬀymetrix). Laser
power and the gain on the photomultiplier tube (PMT)
were kept constant during scanning of each individual
slide. The PMT setting was chosen so that the highest
intensity values lied below the saturation point. Both
channels were normalized against each other using Jag-
uar software. Spot intensity and background signals
were quantiﬁed for each channel and used to generate
spreadsheet data for Microsoft Excel.
3. Results
3.1. Schematic representation of microarray steps
The steps involved in the microarray strategy that we
have used are shown in Fig. 1. Clones from three un-
ampliﬁed mouse eye libraries were sequence-tagged and
analyzed to determine their identity. Inserts from these
cDNAs were isolated and puriﬁed prior to printing.
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I-Gene microarrays were printed at 22–24 C with a
relative humidity of 55–65%. Cy-labeled cDNAs were
used as targets to hybridize the slides. Images of Cy3
and Cy5 were acquired by laser scanning and analyzed
using Jaguar 2.0.
3.2. Characterization of the mouse cDNA libraries
Unampliﬁed libraries from mouse E15.5 and PN2
eyes, and from adult retina were generated in pSPORT1
plasmid vector. More than 90% of the clones had an
Fig. 1. (a, b) A schematic representation of the microarray strategy.
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average insert size of 1.5 kb. Almost 2500 clones from
each of the three libraries have been isolated and stored
in triplicate as glycerol stocks in 96-well plates. Of these,
3188 have been sequenced at the 50 end and the se-
quences analyzed (Fig. 2). 1952 cDNA clones show
strong homology to known genes or ESTs, whereas 886
clones are classiﬁed as novel ESTs. A total of 99 clones
matched ribosomal genes, 152 matched mitochondrial
genes, and 99 clones gave poor sequencing results.
3.3. Preparation of DNA inserts for printing
Two rounds of PCR are performed on each glycerol
stock in order to increase the yield of cDNA inserts
required for printing of slides. After puriﬁcation, the
average yield is approximately 3 lg per clone with a
PCR success rate of >90%. Puriﬁed PCR products are
vacuum dried and resuspended in 3X SSC at an average
concentration of 200 ng/ll.
3.4. Printing
Spots with 100 lm diameter are printed with Stealth
pins (Telechem) using SDDC-2 arrayer (Virtek ESI).
Samples are pre-printed eight times onto a blotting glass
before the slides are printed. The pins are washed with
H2O in four cycles of 6 s each and dried between
samples.
3.5. Hybridization and analysis of slides
Slides containing over 2000 clones (printed in dupli-
cate) have been utilized to optimize protocols involved
in printing, arraying, dye labeling, hybridization, and
scanning. We have performed multiple hybridizations
using an identical RNA target (from a P19 embryonic
carcinoma cell line or N1E-115 neuroblastoma stem
cells) labeled with both Cy3 and Cy5 respectively. Ex-
periments were performed to compare hybridizations of
P19 (Cy3) vs. P19 (Cy5) and N1E-115 (Cy3) vs. N1E-
115 (Cy5) targets. Since the targets in each experiment
are same, hybridizations intensities from each channel
should be identical. However, Cy3 and Cy5 have dif-
ferent levels of incorporation in RNA during the label-
ing step. This is corrected by normalizing the Cy3 and
Cy5 channels so that the total measured ﬂuorescence
intensity is equal between the two channels (Hegde et al.,
2000; Quackenbush, 2001). The total integrated inten-
sities across all spots in one channel should be equal to
the other channel, especially when the RNA targets are
the same. Spots are classiﬁed as outliers if they have
intensity values that are less than the background or
close to 0, or if the spot has very high intensity. These
Fig. 2. Pie charts representing diﬀerent clone types identiﬁed in our mouse eye libraries. Currently a total of 3188 cDNA clones have been sequenced
and analyzed.
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outliers were removed prior to data analysis. Jaguar 2.0
was used to generate synthetic images for each channel
and calculate intensity ratios for each experiment (Fig.
3). Methods for direct and indirect labeling were tested
and used in multiple experiments. After scanning and
data analysis, 90–95% of the spots have a ratio between
2 and þ2, demonstrating relatively equal amounts of
hybridization at both the Cy3 and Cy5 channels (Fig. 4).
Repetitive experiments illustrate that false positives are
recognizable. Some spots appear to show a change
greater than two-fold between the two samples; how-
ever, when multiple experiments are performed, the av-
erage ratio of these spots no longer reveals a signiﬁcant
change in the expression level. As for labeling methods,
our data indicates that indirect labeling may be a more
eﬀective and reproducible method and provide better
data. With indirect labeling, the slope of a scatter plot
produced by the data set is also closer to one and the
signal/noise ratio was signiﬁcantly higher.
4. Discussion
4.1. Generation of eye-expressed ESTs
We have isolated 7500 clones from mouse eye/retina
cDNA libraries; of these, 3188 have been sequenced so
far. Almost 30% of these sequences do not show sig-
niﬁcant homology to any known gene or EST in the
public databases, further conﬁrming an under-repre-
sentation of eye genes. Many cDNAs reveal homology
to the genomic sequence (continuously being deposited
as part of the Human Genome Project), which can be
used to elucidate their gene structure and chromosomal
location. This can assist in the identiﬁcation of potential
candidate genes for retinal/eye diseases. A non-redun-
dant set of clones is currently being organized into new
stocks, which will be used to print the I-Gene arrays.
ESTs from additional mouse eye libraries may be added
to augment this non-redundant set of clones.
Fig. 3. A typical microarray experiment with identical target RNAs. Jaguar 2.0 software (Aﬀymetrix) calculates pixel intensity minus background
and generates a synthetic image for both the Cy3 and Cy5 channels. These images are then overlaid to generate a composite synthetic image that can
be used for qualitative analysis. Yellow spots have an equal amount of hybridization from the Cy3 and Cy5 targets.
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4.2. I-gene arrays
Currently, slides are being printed with >6000 clones.
These slides have permitted us to optimize the hybrid-
ization methodology and perform several experiments.
Although our current protocols are generating accept-
able data, additional standardizations may be necessary
to further reduce the inter- and intra-slide variability.
Multiple experiments must be performed when
working with microarrays to minimize diﬀerences be-
tween tissue samples that can lead to false positives and
to obtain statistically signiﬁcant data. It is also necessary
to use identical methodology to reduce experimental
variations. Although microarray experiments provide
researchers with semi-quantitative data, it is possible to
develop algorithms that will convert microarray ratios
into true fold changes in gene expression. In any event,
the experimental results obtained from microarray
analysis must be conﬁrmed using Northern blots and/or
quantitative reverse transcription-PCR.
Microarray technology still needs better methods for
image acquisition and data analysis. Inter-experiment
and inter-personnel variations are a signiﬁcant problem.
At times, investigators may also need to directly com-
pare data generated by diﬀerent laboratories. Utilization
of a common target RNA (i.e., reference RNA) can
provide better normalization of results for studying
changes in gene expression (Basset, Eisen, & Boguski,
1999). Even where the experimental design involves a
straightforward comparison of two RNA species, use of
reference RNA will permit better normalization of spot
intensities and provide tools for statistical analysis of the
data. The utilization of identical mouse I-gene cDNA
microarrays and standard methodologies by diﬀerent
laboratories should permit additional cluster analysis of
microarray data and lead to better insights into cellular
pathways involved in eye/retinal development and dis-
ease pathogenesis.
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